Trials / Completed
CompletedNCT03672383
Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)
Randomized, Controlled, Observer-blinded, Intra-individual Clinical Trial to Examine the Efficacy and Safety of a New Medical Device (Modified Diprobase Formulation) in Adults With Quiescent Atopic Dermatitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial is intended to investigate the efficacy and safety of a medical device compared to untreated on patients with quiescent atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BAY987534 | Form: cream; Route of Administration: topical; Frequency of Administration: twice daily ; Duration of Treatment: 4 weeks . |
Timeline
- Start date
- 2018-09-17
- Primary completion
- 2018-10-17
- Completion
- 2018-10-17
- First posted
- 2018-09-14
- Last updated
- 2019-09-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03672383. Inclusion in this directory is not an endorsement.